Back to results
US 2026/0138959 A1Published application
Quinazoline derivative compound and use thereof
AssigneeVoronoi Inc.
InventorsMyungho JUNG, Hyeonho JEON, Jungbeom SON, Namdoo KIM, Sunghwan KIM
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to quinazoline derivative compounds and medicinal uses thereof. Specifically, the present disclosure provides compounds capable of treating or preventing c-KIT or PDGFR-related diseases by inhibiting c-KIT or PDGFR.
Claims16
A compound represented by the Chemical Formula 1 below, a stereoisomer thereof, or a pharmaceutically acceptable salt thereof:
- in the Chemical Formula 1,
- R1 and R2 are each independently —H, —(C1-C6)alkyl, —(CH2)m—Rx, or —(C═O)—Rx {wherein, R1 and R2 cannot be methyl at the same time};
- Rx is —(C1-C6)alkoxy, —NRARB, -halo, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, or heterohydroaryl {wherein at least one H in the cycloalkyl or heterocycloalkyl ring may be substituted with —(C1-C6)alkyl, —(C1-C6)hydroxyalkyl, —(C1-C6)alkyl-O—(C1-C6)alkyl, —(C═O)—(C1-C6)alkyl, —(C═O)—O—(C1-C6)alkyl, —NRCRD, —(═O)—, cycloalkyl, or benzyl, [wherein, at least one H in the benzyl ring may be substituted with —(C1-C6)alkyl, —(C1-C6)alkoxy, —(C1-C6)haloalkyl, or halo];
- at least one H in the aryl, heteroaryl, or heterohydroaryl ring may be substituted with —(C1-C6)alkyl, —(C1-C6)haloalkyl, or halo};
- RA and RB are each independently —H, —(C1-C6)alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl {wherein, at the least one H in the cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring may be substituted with —(C1-C6)alkyl};
- RC and RD are each independently —H or —(C1-C6)alkyl;
- m is 0, 1, 2, 3, or 4;
- R3 is —H, —(C1-C6)alkyl, —(C1-C6)alkoxy, or -halo;
- L is —NH(C═O)-L1-(CH2)n-L2-, —NH—S(═O)2-L1-(CH2)n-L2-, —(C═O)NH-L1-(CH2)n-L2-, -L1-(CH2)n-L2-(C═O)NH—, or —NH(C═O)NH—;
- L1 and L2 are each independently —CRERF—, —C(═O)NH—, or null;
- RE and RF are each independently —H, —(C1-C6)alkyl, —NH2, —NH(C═O)O—(C1-C6)alkyl, —OH, or -halo, or RE and RF are combined with carbon to form —(C3-C6)cycloalkyl;
- n is 0, 1, 2, 3, or 4;
- Z is aryl, heteroaryl, heterohydroaryl, cycloalkyl, heterocycloalkyl, or —(C2-C6)alkenyl {wherein, at least one H in the aryl, heteroaryl, or heterohydroaryl ring may be substituted with —(C1-C6)alkyl, —(C1-C6)haloalkyl, —(C1-C6)hydroxyalkyl, —(C1-C6)cyanoalkyl, —CN, —NRGRH, —(C1-C6)alkoxy, or -halo;
- at least one H in the cycloalkyl or heterocycloalkyl ring may be substituted with —(C1-C6)alkyl};
- RG and RH are each independently H or —(C1-C6)alkyl.
12 more elements
-17. (canceled)
Dependencies are inferred from the claim text.